Latest Stock Split Details
Key information about Canntab Therapeutics Limited's most recent stock split
Split Date: 2018-04-20
Split Ratio: 1:200
Price Before Split: $0.05
Price After Split: $0.00
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 200.00 times fewer shares (a 1:200 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Canntab Therapeutics Limited's stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2018-04-20 | 1:200 | Yes | $0.05 | $0.00 |
About Canntab Therapeutics Limited
Company overview and industry information
Canntab Therapeutics Limited (CTABF) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 1-for-200 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Drug Manufacturers - Specialty & Generic
Go to Canntab Therapeutics Limited Summary